Chimeric non-integrating lentiviral genomes as vaccines against hiv-1
AssigneesBoe Technology Group Co., Ltd., Chengdu Boe Optoelectronics Technology Co., Ltd.
InventorsYahia Chebloune, Delphine Aldebert, Géraldine Arrode-Bruses
Life of this patent
Estimating the term…
Abstract
Novel nucleic acids include non-integrative chimeric retroviral genomes including the 5′ and 3′ long terminal repeat sequences (LTRs) of the caprine lentivirus: the Caprine Arthritis Encephalitis Virus (CAEV) or of another retrovirus not integrating human cells and at least one viral gene of another retrovirus. A vector including such a nucleic acid, an immunogenic or vaccinal composition including the vector or the nucleic acid, as well as their use for treating and/or preventing an infection by a retrovirus or a disease induced by a pathogenic agent are also described.
Claims20
1-19. (canceled)
A nucleic acid comprising a chimeric retroviral genome, in which said chimeric retroviral genome comprises:
- long terminal repeat sequences (LTR) in 5′ and in 3′ of a first retrovirus, said first retrovirus being the Caprine Arthritis Encephalitis Virus (CAEV), the Visna Maedi Virus (VMV), the Equine Infectious Anaemia Virus (EIAV), an oncovirus, or a spumavirus, and
- at least one viral gene of a second retrovirus, said second retrovirus not being the first retrovirus.
Dependencies are inferred from the claim text.